Pre-Open Stock Movers:

Bed Bath & Beyond (NASDAQ: BBBY) 28.4% LOWER; reported Q2 EPS of $0.04, $0.48 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $1.99 billion versus the consensus estimate of $2.06 billion. Bed Bath & Beyond sees Q3 2021 EPS of $0.00-$0.05, versus the consensus of $0.28. Bed Bath & Beyond sees Q3 2021 revenue of $1.96-2 billion, versus the consensus of $2.02 billion. Bed Bath & Beyond sees FY2021 EPS of $0.70-$1.10, versus the consensus of $1.51. Bed Bath & Beyond sees FY2021 revenue of $8.1-8.3 billion, versus the consensus of $8.31 billion.

Bit Digital, Inc. (Nasdaq: BTBT) 18.3% LOWER; entered into a definitive agreement with institutional investors to purchase 13,490,728 ordinary shares in a private placement. The Company will also issue to the investors unregistered warrants to purchase up to an aggregate of 10,118,046 ordinary shares. The purchase price for one ordinary share and one warrant to purchase three-fourths of an ordinary share is $5.93.

Perrigo Company (NYSE: PRGO) 15.4% HIGHER; reached a settlement with the Irish Office of the Revenue Commissioners for the Notice of Amended Assessment (NoA) to settle the 1.64 billion tax assessment. Perrigo will pay EUR 297 million as a full and final settlement.

Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) 14.1% LOWER; announced it has commenced an underwritten public offering of shares of its common stock and warrants.

Aemetis, Inc. (NASDAQ: AMTX) 13.5% HIGHER; signed with Delta Air Lines for 250 million gallons of blended fuel containing sustainable aviation fuel (“SAF”) to be delivered over the 10 year term of the agreement. The aggregate value of the agreement is estimated to be more than $1 billion, including LCFS, RFS, 45Q and tax credits

Landec (NASDAQ: LNDC) 10% LOWER; reported Q4 EPS of ($0.23), $0.11 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $128.8 million versus the consensus estimate of $129.1 million.

Orion Group Holdings, Inc. (NYSE: ORN) 10% HIGHER; announced two contract awards for its Marine segment totaling nearly $200 million.

Virgin Galactic Holdings, Inc. (NYSE: SPCE) 8% HIGHER; The U.S. Federal Aviation Administration (FAA) closed its mishap investigation into the July 11 Virgin Galactic Unity 22 launch, which deviated from assigned airspace on the descent.

CarMax (NYSE: KMX) 8% LOWER; reported Q2 EPS of $1.72, $0.18 worse than the analyst estimate of $1.90. Revenue for the quarter came in at $8 billion versus the consensus estimate of $6.9 billion.

Kohl's (NYSE: KSS) 7.4% LOWER; BofA Securities downgraded from Buy to Underperform with a price target of $48.00 (from $75.00).

Lordstown Motors (NASDAQ: RIDE) 6.5% HIGHER; is near an agreement to sell its Ohio factory to Taiwan's Foxconn, according to Bloomberg, citing people familiar with the matter.

Rocket Lab USA (NASDAQ: RKLB) 4.7% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $22.00.

Affimed Therapeutics (NASDAQ: AFMD) 4.1% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $12.00.

Amicus Therapeutics (NASDAQ: FOLD) 4% HIGHER; JPMorgan upgraded from Neutral to Overweight with a price target of $16.00.

Vir Biotechnology, Inc. (NYSE: VIR) 3.4% HIGHER; announced significant progress increasing global patient access to sotrovimab, an investigational monoclonal antibody treatment for COVID-19 developed in partnership with GlaxoSmithKline (NYSE: GSK). To date, binding agreements have been received for the sale of more than 420,000 doses of sotrovimab worldwide, including a portion of those procured by the U.S. government. In addition, more than 220,000 doses have been reserved through other agreements. The companies continue discussions with governments around the world for additional agreements that can support the ongoing pandemic response.

Snowflake Inc. (NYSE: SNOW) 2.6% HIGHER; BTIG upgraded from Neutral to Buy with a price target of $353.00.

Workhorse Group Inc. (Nasdaq: WKHS) 1.6% LOWER; CFO resigns.

Herman Miller (NASDAQ: MLHR) 1.6% HIGHER; reported Q1 EPS of $0.49, $0.07 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $789.7 million versus the consensus estimate of $654.47 million. The company provided its Q2/22 outlook, including Knoll, expecting revenue to range between $1,025 million and $1,065 million and EPS to be between $0.55 and $0.61.